NCT05718323 2026-02-06
RAISE
ETOP IBCSG Partners Foundation
Phase 2 Recruiting
Clinical Trials
4 trialsNCT07141264 2025-12-30
Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy
Tang-Du Hospital
Phase 2 Recruiting
NCT07289048 2025-12-17
A Prospective, Single-Arm, Exploratory Study of IBI363 in ES-SCLC Patients After Immunotherapy Progression
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Not yet recruiting
NCT05623319 2025-06-24
THOR
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Recruiting